191 related articles for article (PubMed ID: 38678238)
41. CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies.
Huang R; Mo D; Wu J; Ai H; Lu Y
Medicine (Baltimore); 2018 Jun; 97(23):e10446. PubMed ID: 29879012
[TBL] [Abstract][Full Text] [Related]
42. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of LGR5 in colorectal cancer: a meta-analysis.
Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P
PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390
[TBL] [Abstract][Full Text] [Related]
44. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
[TBL] [Abstract][Full Text] [Related]
45. Multifaceted Roles of TRIM Proteins in Colorectal Carcinoma.
Eberhardt W; Haeussler K; Nasrullah U; Pfeilschifter J
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066016
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
47. [Relationship Between Tim-3 and Galectin-9 Expression Levels, Clinical Pathological Characteristics, and Prognosis in Patients After Radical Resection of Colorectal Cancer].
Zhang Y; Deng D; Yin W; Luo J; Liu J; Xie C; Ji X; Ma L; Zhang L; Xia X; Cheng S; Huang A; Yang F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):375-382. PubMed ID: 38645842
[TBL] [Abstract][Full Text] [Related]
48. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ji K; Zhang M; Chu Q; Gan Y; Ren H; Zhang L; Wang L; Li X; Wang W
PLoS One; 2016; 11(8):e0160125. PubMed ID: 27504822
[TBL] [Abstract][Full Text] [Related]
49. Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update.
Chang K; Jiang L; Sun Y; Li H
Mol Diagn Ther; 2022 Jul; 26(4):397-409. PubMed ID: 35732878
[TBL] [Abstract][Full Text] [Related]
50. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
51. Circular RNA MYLK as a prognostic biomarker in patients with cancers: A systematic review and meta-analysis.
Foroumadi R; Rashedi S; Asgarian S; Mardani M; Keykhaei M; Farrokhpour H; Javanshir S; Sarallah R; Rezaei N
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1653. PubMed ID: 35701309
[TBL] [Abstract][Full Text] [Related]
52. Prognostic Implications of Tripartite Motif Containing 24 Expression Levels in Patients with Solid Tumors: A Systematic Review and Meta-Analysis.
He Y; Peng KW; Tang T; Deng L; Ye ZL; Luo MJ; Sun LY; You CX; Shao JY
Genet Test Mol Biomarkers; 2019 Jul; 23(7):473-479. PubMed ID: 31211611
[No Abstract] [Full Text] [Related]
53. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
54. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
[TBL] [Abstract][Full Text] [Related]
55. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis.
Zhou N; Gu Q
Medicine (Baltimore); 2018 Mar; 97(12):e0195. PubMed ID: 29561443
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological and prognostic significance of zinc finger antisense 1 overexpression in cancers: A meta-analysis.
Leng Y; Luo Q; Chen X; Chen F; Wang X; Pan Y
Medicine (Baltimore); 2018 Dec; 97(49):e13378. PubMed ID: 30544408
[TBL] [Abstract][Full Text] [Related]
57. Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis.
Huang CY; Zhou QY; Hu Y; Wen Y; Qiu ZW; Liang MG; Mo JL; Xu JH; Sun C; Liu FB; Chen XL
Oncotarget; 2017 Apr; 8(14):23459-23469. PubMed ID: 28423584
[TBL] [Abstract][Full Text] [Related]
58. Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis.
Shang W; Yan C; Liu R; Chen L; Cheng D; Hao L; Yuan W; Chen J; Yang H
BMC Cancer; 2021 Jul; 21(1):770. PubMed ID: 34217244
[TBL] [Abstract][Full Text] [Related]
59. The predictive value of circular RNAs in the diagnosis, prognosis and clinicopathological features of thyroid cancer: A systematic review and meta-analysis.
Zhu C; Feng Z; Hong F; Sun H; Wang Z; Zhao Z; Zhang F
Pathol Res Pract; 2022 Aug; 236():153871. PubMed ID: 35797852
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological and Prognostic Significance of CBX3 Expression in Human Cancer: a Systematic Review and Meta-analysis.
Lin H; Zhao X; Xia L; Lian J; You J
Dis Markers; 2020; 2020():2412741. PubMed ID: 33273987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
